Doximity, Inc. (DOCS)

NYSE: DOCS · IEX Real-Time Price · USD
40.61
+3.30 (8.84%)
Aug 8, 2022 4:00 PM EDT - Market closed
8.84%
Market Cap 7.77B
Revenue (ttm) 361.52M
Net Income (ttm) 144.90M
Shares Out 191.31M
EPS (ttm) 0.70
PE Ratio 58.01
Forward PE 84.03
Dividend n/a
Ex-Dividend Date n/a
Volume 4,438,547
Open 37.12
Previous Close 37.31
Day's Range 36.61 - 43.10
52-Week Range 27.06 - 107.79
Beta n/a
Analysts Buy
Price Target 48.52 (+19.5%)
Earnings Date Aug 4, 2022

About DOCS

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity,... [Read more...]

Industry Health Information Services
IPO Date Jun 24, 2021
Employees 887
Stock Exchange NYSE
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2021, Doximity's revenue was $343.55 million, an increase of 66.05% compared to the previous year's $206.90 million. Earnings were $154.78 million, an increase of 208.27%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price forecast is 48.52, which is an increase of 19.48% from the latest price.

Price Target
$48.52
(19.48% upside)
Analyst Consensus: Buy
Stock Forecasts

News

We were surprised by macro headwinds, seems healthcare isn't immune, says Doximity CEO

Jeff Tangney, Doximity CEO, joins 'TechCheck' to discuss the issues with the company's quarterly earnings results, Doximity's plans for diversification and Tangney's thoughts on tele-health prospects in...

Why Doximity Stock Is Sinking Today

Investors didn't like one part of the company's latest quarterly update.

Doximity (DOCS) Tops Q1 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 27.27% and 1.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Doximity Underscores Commitment to Corporate Social Responsibility with Launch of ESG Website

Company's mission to support clinicians aligned with ESG commitments and impact SAN FRANCISCO , Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical pr...

Doximity Appoints Phoebe Yang to Its Board of Directors

Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical profess...

Doximity Announces Fiscal 2023 First Quarter Financial Results

Q1 total revenues of $90.6 million , up 25% year-over-year Q1 operating cash flow of $44.8 million, up 35% year-over-year Q1 free cash flow of $42.6 million, up 32% year-over-year SAN FRANCISCO , Aug. 4...

Want $1 Million in Retirement? Invest $150,000 in These 3 Stocks and Wait a Decade

These healthcare stocks could help you retire early, offering impressive margins and promising growth potential.

Other symbols: MEDPVEEV

3 Best Telehealth Stocks to Buy Now

The global telehealth market is expected to grow to $300 billion by 2028. Here are three of the best telehealth stocks to ride the wave.

Other symbols: AMWLCI

3 Healthcare Stocks That Are Raising Guidance in 2022

Here's why investors in InMode, Shockwave Medical, and Doximity are excited about the rest of 2022.

Other symbols: INMDSWAV

3 Best Telehealth Stocks To Buy Now

The best telehealth stocks are undervalued after an abrupt sell-off. There are a few names such as TDOC, DOCS and HUM that stand out.

Other symbols: HUMTDOC

SVB Leerink Sees 'Cheaper Way' To Pharma Digital Marketing With This Stock

SVB Leerink initiated coverage on OptimizeRx Corporation (NASDAQ: OPRX) with a buy rating and a price target of $38, implying an upside of 36%. The analysts say OptimizeRx is the largest EHR-embedded me...

Other symbols: OPRX

AVTR or DOCS: Which Is the Better Value Stock Right Now?

AVTR vs. DOCS: Which Stock Is the Better Value Option?

Other symbols: AVTR

3 Top Tech Stocks to Buy for the Long Haul

Tech stocks are hurting right now, but these companies could prove to be great long-term plays.

Other symbols: MSFTNVDA

Doximity to Release Fiscal 2023 First Quarter Results on August 4, 2022

SAN FRANCISCO , July 14, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its first qua...

Is Doximity a Buy?

The decline in share price may not be all that surprising given Doximity's egregious valuation last year.

1 Under-the-Radar Growth Stock to Buy in July

This platform for medical professionals is worth a closer look.

My 3 Favorite Stocks Right Now

These three companies are leading an internet revolution in retailing, finance, and healthcare.

Other symbols: SHOPSI

Why Doximity Stock Fell More Than 11% This Week

Growth stocks finished off an absolutely terrible first half of the year.

Beyond Stock Splits: 3 Top Growth Stocks to Buy Now

Instead of stock splits, you might want to focus on these three stellar businesses.

Other symbols: DDOGMELI

AVTR vs. DOCS: Which Stock Is the Better Value Option?

AVTR vs. DOCS: Which Stock Is the Better Value Option?

Other symbols: AVTR

Doximity (DOCS) Surges 6.6%: Is This an Indication of Further Gains?

Doximity (DOCS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High

Here's why our roundtable likes Intellia Therapeutics, Doximity, and TransMedics.

Other symbols: NTLATMDX

2 Top Healthcare Stocks Near 52-Week Lows to Buy

These two businesses are stronger than ever, but their stock prices are at their lowest points in at least a year.

Other symbols: ABT

Doximity Inc.: A Healthy Value Stock

Doximity Inc. ( DOCS , Financial) appears at first glance to be a health care stock, but it's also a tech stock. In fact, Doximity operates in telehealth fielding education, promoting communication and ...

Doximity Stock is an Interesting Healthcare Play

Cloud-based healthcare community platform Doximity (NASDAQ: DOCS) stock may be put in a bottom as its trades down (-35%) for the year.